🇨🇦 Insulin LISPRO intravenous loading in Canada

Insulin LISPRO intravenous loading (Insulin LISPRO intravenous loading) regulatory status in Canada.

Marketing authorisation

Insulin LISPRO intravenous loading in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Insulin LISPRO intravenous loading approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Insulin LISPRO intravenous loading in Canada?

Rambam Health Care Campus is the originator. The local marketing authorisation holder may differ — check the official source linked above.